Caption Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-32,362
Closed -$700K 2015
2025
Q3
$700K Sell
32,362
-103,315
-76% -$2.3M 0.01% 1218
2025
Q2
$3.02M Buy
+135,677
New +$3.02M 0.03% 583
2025
Q1
Sell
-208,033
Closed -$4.92M 1988
2024
Q4
$4.4M Buy
+208,033
New +$5.46M 0.04% 405
2024
Q3
Sell
-35,100
Closed -$835K 1567
2024
Q2
$835K Buy
+35,100
New +$901K 0.01% 710
2023
Q4
Sell
-9,475
Closed -$275K 1633
2023
Q3
$277K Buy
+9,475
New +$341K ﹤0.01% 1055
2023
Q2
Sell
-32,354
Closed -$1.23M 1376
2023
Q1
$1.12M Sell
32,354
-3,934
-11% -$128K 0.02% 607
2022
Q4
$1.01M Buy
36,288
+4,858
+15% +$129K 0.02% 749
2022
Q3
$736K Buy
31,430
+17,330
+123% +$553K 0.01% 971
2022
Q2
$408K Buy
+14,100
New +$616K 0.01% 1113

Other funds holding SGRY

Caption Management's SGRY Position: Q4 2025 in Review

Caption Management sold out of Surgery Partners (SGRY) in Q4 2025, closing a stake of 32,362 shares — an estimated $700K sold.

Caption Management first reported a position in SGRY in Q2 2022 and held it in 9 quarters. The position peaked at $4.4M in Q4 2024. 181 funds tracked by Wall St. Rank hold SGRY as of Q4 2025.

  • Caption Management reported no remaining Surgery Partners position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 32,362 Surgery Partners shares in Q4 2025, an estimated $700K.
  • Caption Management first reported a position in Surgery Partners in Q2 2022 and held it in 9 quarters.
  • Caption Management's Surgery Partners position peaked at $4.4M in Q4 2024.
  • 181 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.